You Position: Home > Paper

CLINICAL VALUE OF SERUM CK-MB IN MALIGNANT PERICARDIAL EFFUSION

( views:277, downloads:16 )
Author:
No author available
Journal Title:
CANCER RESEARCH AND CLINIC
Issue:
3
DOI:
10.3760/cma.j.issn.1006-9801.2003.03.006
Key Word:
恶性肿瘤;心包积液;肌酸激酶同工酶MB;检测

Abstract: 目的:探讨血清CK-MB检测在癌性心包积液治疗中的临床价值.方法:以免疫抑制法测定血清CK-MB 5次:入院、出院及出院后3月内每月1次.观察组包括54例癌性心包积液,对照组为54例不伴心包积液的癌症患者.结果:观察组血清CK-MB的阳性率高于对照组,分别为79.6%(43/54)和35.18%(19/54),且在观察组中的降低和/或升高与疗效相关,且差异有显著性;而对照组差异无显著性.结论:血清CK-MB含量与癌细胞浸润心包有关,其对癌性心包积液患者的病情、疗效、复发及预后评估有一定的参考价值.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn